These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8747785

  • 1. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.
    van der Burg MP, Guicherit OR, Frölich M, Gooszen HG.
    Regul Pept; 1995 Dec 07; 60(1):61-7. PubMed ID: 8747785
    [Abstract] [Full Text] [Related]

  • 2. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC, Göke R, Göke B, Bächle R, Wagner B, Arnold R.
    Biochim Biophys Acta; 1991 Feb 19; 1091(3):356-63. PubMed ID: 1705823
    [Abstract] [Full Text] [Related]

  • 3. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Watanabe Y, Yamashita K.
    Metabolism; 1992 Apr 19; 41(4):359-63. PubMed ID: 1556941
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
    Siegel EG, Schulze A, Schmidt WE, Creutzfeldt W.
    Eur J Clin Invest; 1992 Mar 19; 22(3):154-7. PubMed ID: 1582439
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.
    Green BD, Gault VA, Flatt PR, Harriott P, Greer B, O'Harte FP.
    Arch Biochem Biophys; 2004 Aug 15; 428(2):136-43. PubMed ID: 15246869
    [Abstract] [Full Text] [Related]

  • 7. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA, O'Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR.
    Diabetologia; 2003 Feb 15; 46(2):222-30. PubMed ID: 12627321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of glucagon-like peptide-1 on beta cell responsiveness.
    Zawalich WS, Zawalich KC, Rasmussen H.
    Regul Pept; 1993 Apr 08; 44(3):277-83. PubMed ID: 8484020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr 08; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, Habener JF, Andersen DK.
    Regul Pept; 1994 Apr 14; 51(1):63-74. PubMed ID: 8036284
    [Abstract] [Full Text] [Related]

  • 15. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
    Fehmann HC, Hering BJ, Wolf MJ, Brandhorst H, Brandhorst D, Bretzel RG, Federlin K, Göke B.
    Pancreas; 1995 Aug 14; 11(2):196-200. PubMed ID: 7479679
    [Abstract] [Full Text] [Related]

  • 16. Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin.
    Hardikar AA, Wang XY, Williams LJ, Kwok J, Wong R, Yao M, Tuch BE.
    Endocrinology; 2002 Sep 14; 143(9):3505-14. PubMed ID: 12193564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, Seino Y, McIntosh CH, Pederson RA.
    Am J Physiol Endocrinol Metab; 2003 May 14; 284(5):E931-9. PubMed ID: 12540373
    [Abstract] [Full Text] [Related]

  • 19. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
    Fehmann HC, Göke B, Göke R, Trautmann ME, Arnold R.
    FEBS Lett; 1989 Jul 31; 252(1-2):109-12. PubMed ID: 2668027
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.